Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

12.51 -0.19 (-1.54%)
Streaming Delayed Price Updated: 10:17 AM EDT, Sep 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novavax Inc

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Via Benzinga
The Lazarus Effect: 3 ‘Dead’ Stocks That Could Rise From the Ashes
These companies, thought dead, could pull a Lazarus and rise from the ashes, making them stocks to buy for a comeback. 
Via InvestorPlace
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
What's Going On With Novavax Shares Monday?
Novavax, Inc. (NASDAQ: NVAX) shares are moving higher on Monday. Here's what you need to know. 
Via Benzinga
Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes
After pulling back following May's "Sanofi surge," don't rule out the potential for further needle-moving news with Novavax stock. 
Via InvestorPlace
Exposures COVID-19
(NVAX) - Analyzing Novavax's Short Interest
Via Benzinga
Decoding Novavax's Options Activity: What's the Big Picture?
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
Via Benzinga
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Trading SMID Biotech Stocks In A Volatile Market
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... 
Via Talk Markets
Where Will Novavax Be in 1 Year?
We will know a lot more about the vaccine maker's long-term prospects in 12 months. 
Via The Motley Fool
Meme Stock or Vaccine Stock? Novavax’s Identity Crisis and Why It Matters for Investors
It's good news for Novavax that the FDA is targeting a particular Covid-19 strain, but Novavax stock is still to pricey to buy now. 
Via InvestorPlace
Exposures COVID-19 Product Safety
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
(NVAX) - Analyzing Novavax's Short Interest
Via Benzinga
3 Meme Stocks to Buy on the Dip: June 2024
Investors can't miss out on meme stocks to buy on the dip since these represent fundamentally sound ideas with growth acceleration catalysts 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
3 Short-Squeeze Stocks Ready to Break the Chains of Bearish Sentiment
These are the short-squeeze stocks to buy as they represent oversold names with positive impending catalysts. 
Via InvestorPlace
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial Company'
Jim Cramer can't recommend Twilio due to recent stock downgrade. He prefers Vistra Corp. and Constellation Energy Corp. for energy market. 
Via Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Is It Too Late to Buy Novavax Stock?
Shares of the vaccine maker are trading up 230% this year. 
Via The Motley Fool
3 Penny Stocks Set to Surge 500% by 2026: June Edition
These are the undervalued penny stocks to buy as they represent emerging companies with potential for robust growth and cash flow upside 
Via InvestorPlace
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio. 
Via InvestorPlace
Exposures Product Safety
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These pharma and biotech players could become long-term winners. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts. 
Via Benzinga
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In May: Where Do Nvidia, Tesla, GameStop, AMC Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1. 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.